tykhr
sign in
free sign up
Arcutis Biotherapeutics Inc
Biotechnology
Healthcare
ARQT
124 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
12.87
52 week high
17.29
high
14.80
52 week low
7.24
low
12.25
growth
74.28 %
previous Close
13.29
P/E ratio
market cap
1.75 B
div yield
0
usd
Sep 2024
qoq
revenue
44.76 M
45.04 %
net incoming
-41.54 M
20.63 %
eps
0.00 %
21.43 %
eps surprise
21.43 %
net profit margin
-92.81 %
76.00 %
operating incoming
-39.07 M
21.99 %
net change in cash
50.58 M
147.80 %
cash on hand
135 M
58.86 %
cost of revenue
5.50 M
58.86 %
top